A SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR DIRECT DETERMINATION OF WARFARIN ENANTIOMERS AND THEIR PROTEIN-BINDING IN STROKE PATIENTS

被引:6
作者
CAI, WM
HATTON, J
PETTIGREW, LC
DEMPSEY, RJ
CHANDLER, MHH
机构
[1] UNIV KENTUCKY,COLL PHARM,DIV PHARM PRACTICE & SCI,LEXINGTON,KY
[2] UNIV KENTUCKY,COLL MED,SANDERS BROWN CTR AGING,STROKE PROGRAM,LEXINGTON,KY
关键词
WARFARIN; ENANTIOMERS; HIGH-PRESSURE LIQUID CHROMATOGRAPHY; PLASMA PROTEIN BINDING; ULTRAFILTRATION; STROKE;
D O I
10.1097/00007691-199410000-00012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A simplified method for direct determination of warfarin enantiomers by high-pressure liquid chromatography with fluorescence detection has been developed. This method involves solid phase extraction of warfarin in plasma, precolumn derivatization to form diastereoisomeric esters, and postcolumn reaction to discriminate each enantiomer separately. Ultrafiltration was employed in the separation of unbound warfarin enantiomers. Twelve plasma samples from six stroke patients taking warfarin regularly were analyzed. The average concentration of total warfarin was 0.47 +/- 0.17 mg/L for the S-isomer and 0.69 +/- 0.18 mg/L for the R-isomer. The average protein binding was 99.67 +/- 0.33% for S-warfarin and 99.44 +/- 0.33% for R-warfarin. This methodology provides a quick and reliable technique for determining enantiomeric protein binding of warfarin in clinical settings.
引用
收藏
页码:509 / 512
页数:4
相关论文
共 13 条
[1]   STEREOSPECIFIC FLUORESCENCE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF WARFARIN AND ITS METABOLITES IN PLASMA AND URINE [J].
BANFIELD, C ;
ROWLAND, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) :1392-1396
[2]   STEREOSPECIFIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF WARFARIN IN PLASMA [J].
BANFIELD, C ;
ROWLAND, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) :921-924
[3]  
BOWERS WF, 1984, CLIN PHARMACOKINET, V9, pS49
[4]  
CHAN E, 1984, BR J CLIN PHARM, V19, pP571
[5]   THE MEASUREMENT OF WARFARIN ENANTIOMERS IN SERUM USING COUPLED ACHIRAL CHIRAL, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY (HPLC) [J].
CHU, YQ ;
WAINER, IW .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :680-683
[6]   MEASUREMENT OF THE (R)-ISOMERS AND (S)-ISOMERS OF WARFARIN IN PATIENTS UNDERGOING ANTICOAGULANT-THERAPY [J].
MCALEER, SD ;
CHRYSTYN, H ;
FOONDUN, AS .
CHIRALITY, 1992, 4 (08) :488-493
[7]   PLASMA-PROTEIN BINDING OF WARFARIN - METHODOLOGICAL CONSIDERATIONS [J].
MUNGALL, D ;
WONG, YY ;
TALBERT, RL ;
CRAWFORD, MH ;
MARSHALL, J ;
HAWKINS, DW ;
LUDDEN, TM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (07) :1000-1001
[8]   PLASMA-PROTEIN BINDING OF LIDOCAINE AND WARFARIN IN INSULIN-DEPENDENT AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
OBYRNE, S ;
BARRY, MG ;
COLLINS, WCJ ;
OCONNOR, P ;
CULLEN, MJ ;
FEELY, J .
CLINICAL PHARMACOKINETICS, 1993, 24 (02) :183-186
[9]  
PORTER RS, 1992, APPLIED PHARMACOKINE, P3101
[10]   PHARMACOKINETIC IMPLICATIONS OF STEREOSELECTIVE CHANGES IN PLASMA-PROTEIN BINDING - WARFARIN SULFINPYRAZONE [J].
TOON, S ;
TRAGER, WF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (11) :1671-1673